Chemistry of Lithium Enolates
烯醇锂的化学性质
基本信息
- 批准号:7880467
- 负责人:
- 金额:$ 30.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-05-01 至 2014-04-30
- 项目状态:已结题
- 来源:
- 关键词:3-hydroxybutanalAcylationAlkylationAnti-Asthmatic AgentsCase StudyChemistryCollaborationsColorectal CancerDNA Sequence RearrangementDrug IndustryFosteringFundingGroup ProcessesInvestigationKineticsLaboratoriesLithiumMethodsNMR SpectroscopyOrganic SynthesisPharmacologic SubstancePhysical condensationProcessProtocols documentationReactionReagentSolutionsStagingStructureabstractingbasecomputational chemistrydesignimprovedprogramspublic health relevance
项目摘要
DESCRIPTION (provided by applicant): Project Summary/Abstract Lithium enolates constitute one of he most important classes of reactive intermediate in organic synthesis. The pharmaceutical industry uses these reagents frequently and on very large scales. In this proposal we describe efforts to understand the underlying chemistry of the most important reactions of lithium enolates. With methods to establish solution structures that dominated the first funding period largely developed, structural studies will be more targeted in support of mechanistic studies. In the most general sense, we will examine how solvation and aggregation influence reactivity. The mechanistic investigations will focus on specific classes of reaction-case studies-that include: (1) aza-aldol condensations; (2) O-silylations; (3) alkylations; (4) acylations; (5) [2,3]- and [3,3]-sigmatropic rearrangements; and (6) nucleophilic aromatic substitutions (SNAr). A uniquely integrated approach based on a combination of NMR spectroscopy, solution kinetics, and computational chemistry will develop an understanding of the mechanistic principles and how to control reactivity and selectivity. By bringing synthetic organic, physical organic, analytical, and computational chemistry together under one roof, we reveal the consequences of solvation and aggregation with an unprecedented clarity.
PUBLIC HEALTH RELEVANCE: Project Narrative Lithium enolates are reactive intermediates used by other academic and pharmaceutical process chemistry laboratories on a daily basis around the globe. Our mechanistic studies described herein are designed to understand and improve their efficacy. The project originated from collaboration with Sanofi-Aventis to develop anti-asthmatics. The proposed funding period includes a collaboration with Amgen as part of their program to synthesize treatments for colorectal cancer.
项目概述/摘要烯醇化锂是有机合成中最重要的反应中间体之一。制药行业经常使用这些试剂,并且规模非常大。在这个建议中,我们描述了努力了解最重要的反应烯醇化锂的基本化学。随着在第一个供资期占主导地位的解决方案结构的建立方法得到很大发展,结构研究将更有针对性地支持机制研究。在最一般的意义上,我们将研究溶剂化和聚集如何影响反应性。机理研究将集中在特定类别的反应案例研究,包括:(1)氮杂-羟醛缩合;(2)O-甲硅烷基化;(3)烷基化;(4)酰化;(5)[2,3]-和[3,3]-σ迁移重排;和(6)亲核芳香取代(SNAr)。基于NMR光谱,溶液动力学和计算化学的组合的独特集成方法将发展对机械原理以及如何控制反应性和选择性的理解。通过将合成有机,物理有机,分析和计算化学放在一个屋檐下,我们以前所未有的清晰度揭示了溶剂化和聚合的后果。
公共卫生关系:烯醇化锂是地球仪上其他学术和制药过程化学实验室每天使用的活性中间体。我们在此描述的机制研究旨在理解和改善其功效。该项目起源于与赛诺菲-安万特合作开发抗哮喘药。拟议的资助期包括与安进公司的合作,作为其综合治疗结直肠癌计划的一部分。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID B. COLLUM其他文献
DAVID B. COLLUM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID B. COLLUM', 18)}}的其他基金
Alkali Metal Chemistry-Structures, Mechanisms, and Applications
碱金属化学-结构、机理和应用
- 批准号:
10393518 - 财政年份:2019
- 资助金额:
$ 30.94万 - 项目类别:
Alkali Metal Chemistry-Structures, Mechanisms, and Applications
碱金属化学-结构、机理和应用
- 批准号:
9912165 - 财政年份:2019
- 资助金额:
$ 30.94万 - 项目类别:
Alkali Metal Chemistry-Structures, Mechanisms, and Applications
碱金属化学-结构、机理和应用
- 批准号:
10605229 - 财政年份:2019
- 资助金额:
$ 30.94万 - 项目类别:
相似海外基金
Greasing endocytosis in plants - understanding the role of S-acylation in receptor kinase function and internalisation
植物中的润滑内吞作用 - 了解 S-酰化在受体激酶功能和内化中的作用
- 批准号:
BB/Y003756/1 - 财政年份:2024
- 资助金额:
$ 30.94万 - 项目类别:
Research Grant
Ghrelin de-acylation inhibitors as novel compounds for Parkinson's dementia
生长素释放肽去酰化抑制剂作为治疗帕金森痴呆症的新型化合物
- 批准号:
MR/Y503435/1 - 财政年份:2024
- 资助金额:
$ 30.94万 - 项目类别:
Research Grant
S-acylation-dependent regulation of cytokine receptor signaling and cardiac maladaptation
细胞因子受体信号传导和心脏适应不良的 S-酰化依赖性调节
- 批准号:
10561406 - 财政年份:2023
- 资助金额:
$ 30.94万 - 项目类别:
Comprehensive analysis of acidic patch binder using histone acylation catalysts
使用组蛋白酰化催化剂综合分析酸性贴片粘合剂
- 批准号:
22KJ1113 - 财政年份:2023
- 资助金额:
$ 30.94万 - 项目类别:
Grant-in-Aid for JSPS Fellows
S-Acylation of transmembrane proteins in the early secretory pathway
早期分泌途径中跨膜蛋白的 S-酰化
- 批准号:
BB/X001504/1 - 财政年份:2023
- 资助金额:
$ 30.94万 - 项目类别:
Research Grant
N-terminal acylation and sorting of Helicobacter pylori lipoproteins and their role in host response to infection
幽门螺杆菌脂蛋白的 N 末端酰化和分选及其在宿主感染反应中的作用
- 批准号:
10584620 - 财政年份:2022
- 资助金额:
$ 30.94万 - 项目类别:
The Molecular Mechanisms of Glycolytic Enzyme S-acylation in Neurons
神经元糖酵解酶S-酰化的分子机制
- 批准号:
576016-2022 - 财政年份:2022
- 资助金额:
$ 30.94万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
Anti-CRISPR-mediated Acylation and Bioreversible Esterification for Precision Genome Editing
用于精准基因组编辑的抗 CRISPR 介导的酰化和生物可逆酯化
- 批准号:
10657417 - 财政年份:2022
- 资助金额:
$ 30.94万 - 项目类别:
High Throughput Screen for Inhibitors of the YEATS2 Histone Acylation Reader
YEATS2 组蛋白酰化酶抑制剂的高通量筛选
- 批准号:
10389517 - 财政年份:2022
- 资助金额:
$ 30.94万 - 项目类别:
Roles of KAT8 complexes in governing histone acylation and mouse cerebral development
KAT8复合物在控制组蛋白酰化和小鼠大脑发育中的作用
- 批准号:
RGPIN-2019-07122 - 财政年份:2022
- 资助金额:
$ 30.94万 - 项目类别:
Discovery Grants Program - Individual